Amazon.com, Inc. (NASDAQ:AMZN) is launching a new consumer payments option on June 9 that will allow businesses that rely on subscription fees to process their monthly bills through the e-commerce giant. Reuters first reported on the new program on June 9, but Amazon confirmed the details with me this morning. Companies ranging from music streaming to magazines would be able to tap the new “pay with Amazon” billing option, as well as mobile carriers. Amazon.com, Inc. (NASDAQ:AMZN) net profit margin is 0.40% and weekly performance is 8.21%. On last trading day company shares ended up $332.41. Analysts mean target price for the company is $419.33. Amazon.com, Inc. (NASDAQ:AMZN) distance from 50-day simple moving average (SMA50) is 5.94%.
BioFuel Energy Corp. (NASDAQ:BIOF) announced that it has entered into a definitive agreement (the “Agreement”) with certain affiliates ofGreenlight Capital, Inc. (“Greenlight”) and James R. Brickman (“Brickman”) pursuant to which the Company will acquire the equity interests of JBGL Builder Finance LLC and certain subsidiaries of JBGL Capital, LP (collectively, “JBGL”) from Greenlight and Brickman. BioFuel Energy Corp. (NASDAQ:BIOF) shares advanced 1.94% in last trading session and ended the day on $5.78. Gross Margin is -4.40% and its return on assets is -11.40 %. BioFuel Energy Corp. (NASDAQ:BIOF) quarterly performance is 85.26%.
Molson Coors Brewing Company (NYSE:TAP) recent resurgence in the market has been attributed’ to improved international sales aided by cost cutting measures that continue to improve profit margins. The company’s shares have increased in value by 26% this year alone, the highest margin among other 15 global rivals. The bulk of Molson Coor’s business is in stable markets that continue to offer better growth opportunities complimented by cost cuts and improved cash flow. Molson Coors Brewing Company (NYSE:TAP) shares moved up 5.36% in last trading session and was closed at $70.71, while trading in range of $66.27- $67.14. Molson Coors Brewing Company (NYSE:TAP) year to date (YTD) performance is 27.47%.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the Company has begun dosing ACH-3422, a uridine-analog nucleotide polymerase inhibitor, for seven days in patients with genotype 1 chronic hepatitis C viral infection (HCV) in its ongoing Phase 1 clinical trial. Proof-of-concept results from this trial are expected to be reported during the fall of 2014. Furthermore, Achillion announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on sovaprevir, an NS3/4A protease inhibitor, to permit the conduct of trials in patients with HCV. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) ended the last trading day at $7.79. Company weekly volatility is calculated as 14.66% and price to cash ratio as 5.37. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) showed a positive weekly performance of 189.59%.
Automatic Data Processing (NASDAQ:ADP) declared a quarterly dividend on Wednesday, April 9th, American Banking & Market News reports. Investors of record on Friday, June 13th will be given a dividend of 0.48 per share on Tuesday, July 1st. This represents a $1.92 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date of this dividend is Wednesday, June 11th. Automatic Data Processing (NASDAQ:ADP) net profit margin is 15.00% and weekly performance is 0.88%. On last trading day company shares ended up $79.40. Analysts mean target price for the company is $81.87. Automatic Data Processing (NASDAQ:ADP) distance from 50-day simple moving average (SMA50) is 2.58%.